Stop AZ vaccination in 9 European countries… Italy and Denmark also join

Input 2021.03.12 08:12 | Revision 2021.03.12 08:18

Health authorities in Denmark, Norway, Italy and Iceland announced on the 11th (local time) that UK pharmaceutical company AstraZeneca will temporarily suspend the use of a new coronavirus infection (Corona 19) vaccine. As a result of reports that blood clots had formed in some who received the vaccine, they took such measures as a preventive measure. As a result, nine countries in Europe have stopped vaccinating the vaccine.

According to the BBC, Danish authorities said in an announcement that day, “there have been cases of severe blood clotting after receiving the AstraZeneca vaccine,” and that the vaccine will be discontinued for the next 14 days. The authorities said that these measures are only taken on a prophylactic basis. “At this time, it is not possible to conclude whether there is a link between this vaccine and blood clots. An investigation is needed.”

Norwegian authorities also expressed concern on the day and said they would stop using the AstraZeneca vaccine while awaiting further information. Italy and Iceland also took the same steps on this day.

Austrian authorities said earlier on the 7th that a 49-year-old female nurse died after receiving AstraZeneca vaccine at a clinic in the northern Zvetl region of “severe blood clotting disorder”. A 35-year-old female nurse at the same clinic said that she was receiving a vaccine and was receiving hospital treatment because she showed pulmonary embolism, where blood clots block the pulmonary blood vessels. The authorities have declared a temporary suspension of vaccination, saying that they will not supply the remaining stock of the vaccine. Following the announcement in Austria, Estonia, Lithuania, Luxembourg and Latvia have stopped vaccinating the vaccine.

In a statement that day, the European Medicines Agency (EMA), which oversees the vaccine policy of the European Union (EU), reiterated its existing position that’there is no evidence that the AstraZeneca vaccine caused the diseases in question’. EMA said the day before, “related diseases were not identified as side effects of the AstraZeneca vaccine in the first place,” and “it is unlikely that the inventory is defective, but the inventory has also been investigated.”

Britain, Sweden, France and Spain have announced that they will continue to receive the AstraZeneca vaccine. AstraZeneca said, “Patient safety is a top priority.”